A-PONASA
From Wikipedia the free encyclopedia
Chemical compound
 | |
| Identifiers | |
|---|---|
| |
| Chemical and physical data | |
| Formula | C25H33NO3S |
| Molar mass | 427.60 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
A-PONASA is a synthetic cannabinoid receptor agonist that has been sold as a designer drug. It is closely related to the previously reported compound CB-13 but with the naphthalene head group replaced with adamantyl, and an unusual sulfonamide linker group.[1][2]
See also
[edit]References
[edit]- ^ "Cumyl-PeGaClone and other recently encountered synthetic cannabinoid receptor agonists. A review of the evidence on their use and harms" (PDF). Advisory Council on the Misuse of Drugs. 2022.
- ^ Andrews R, Jorge R, Christie R, Gallegos A (April 2023). "From JWH-018 to OXIZIDS: Structural evolution of synthetic cannabinoids in the European Union from 2008 to present day". Drug Testing and Analysis. 15 (4): 378–387. doi:10.1002/dta.3422. PMID 36507715. S2CID 254610773.
| Receptor (ligands) |
| ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Transporter (modulators) |
| ||||||||||||||||||||||||||||||
| Enzyme (modulators) |
| ||||||||||||||||||||||||||||||
| Others |
| ||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
 | This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://en.wikipedia.org/w/index.php?title=A-PONASA&oldid=1253143567"